Where Zongzi Meets Confucian Wisdom: Splendid Dragon Boat Celebrations at Guiyang Confucius Academy
GUIYANG, China, June 25, 2026 /PRNewswire/ -- A news report by Huanqiu.com From June 14 to 19, Guiyang Confucius Academy leveraged the festive occasion to host a rich array of Dragon Boat Festival activities including folk custom experiences,...
Shrewsbury International School Hong Kong Meets Overwhelming Demand for Global Pathway with Additional Year 7 Class
HONG KONG, June 22, 2026 /PRNewswire/ -- Following the highly successful launch of its Key Stage 3 in March, Shrewsbury International School Hong Kong has officially accelerated its mission to develop into a premium through-train school. At its...
Gan & Lee Pharmaceuticals Achieves Significant Progress in Its Dual Pipeline for Metabolic Diseases -- Weekly Insulin Ludefen (GZR4) Meets Primary Endpoint in Phase III Clinical Trial in China; Bofanglutide Meets Primary Endpoints in Phase III Weight
BEIJING and BRIDGEWATER, N.J., June 12, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (hereinafter "Gan & Lee", stockcode: 603087.SH) announced that two of its core pipeline products in the fields of diabetes and obesity treatment have...
eSUN Prime Day Meets the World Cup: Why PETG is Dominating 3D Printing
WUHAN, China, June 5, 2026 /PRNewswire/ -- As Amazon Prime Day aligns with the World Cup, a global shopping celebration begins. eSUN is launching massive promotions across its U.S., U.K., and German Amazon stores, offering up to 60% off on a wide...
MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control
- Achieved statistical significance versus standard-of-care (SOC) control across all key efficacy endpoints in the 52-week study - Japan Phase 3 results strengthen CARTISTEM's® global commercial prospects, with Japan biologics license application...
BGM0504 Achieves 19.3% Robust Weight Reduction, 16.5 cm Waist Circumference Decrease, Significant SBP/DBP Improvements of 22.9/12.9 mmHg, and 70.7 μmol/L Uric Acid Reduction; Phase III Trial Meets Primary Endpoint and All Key Secondary Endpoints
SUZHOU, China, May 5, 2026 /PRNewswire/ -- BrightGene Bio-Medical Technology Co., Ltd. (hereinafter referred to as " BrightGene Bio-Medical" or "the Company") announced that its proprietary GLP-1 (glucagon-like peptide-1)/GIP (glucose-dependent...
Baby Shark Meets Generative AI in a New Interactive Experience
Early-bird tickets now on sale for a generative AI–powered exhibition featuring real-time character interaction Debuting June 18, the exhibition introduces AI-driven storytelling through live interactions with Baby Shark characters Download images...
Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2
BEIJING and BRIDGEWATER, N.J., March 31, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (SSE: 603087) today announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating investigative once-weekly insulin GZR4 Injection,...
Valentine's Day Meets Summer-Ready Homes: Tineco's Smart Cleaning Gifts for Modern Living
SEATTLE, Feb. 12, 2026 /PRNewswire/ -- Valentine's Day arrives in Australia at the height of summer. During this season, cleaning shifts from a routine obligation to something that quietly supports a modern way of living. From sandy floors and pet...
GAC AION V Meets Nordic Pure Electric Needs with Multi-Dimensional Advantages
JAKARTA, Indonesia, Jan. 28, 2026 /PRNewswire/ -- On September 23, 2025, AION V, GAC's global strategic model, was officially launched in Finland. As the third market in Europe where GAC has officially launched its products, Finland marks another...